Elanco Animal Health (NYSE: ELAN) awards CEO new deferred stock units

Q: What insider transaction did Elanco (ELAN) CEO Jeffrey N. Simmons report?

Jeffrey N. Simmons reported an acquisition of deferred stock units as part of his compensation. He received 113.8973 deferred stock units , each tied to Elanco common stock or its cash equivalent, under the company’s Executive Deferral and Stock Match Plan.

Q: How many deferred stock units did Elanco (ELAN) grant to its CEO in this report?

Elanco granted its CEO 113.8973 deferred stock units . These units are referenced at $24.8200 per unit and each represents the right to receive one share of Elanco common stock or the cash equivalent in the future, subject to the plan’s terms.

Q: When will the Elanco (ELAN) deferred stock units reported by the CEO settle?

The reported deferred stock units will settle in cash or shares after the executive’s termination of employment or during a specified future year. Settlement timing follows the rules of Elanco’s Executive Deferral and Stock Match Plan , rather than occurring at grant date.

Q: How many deferred stock units does Elanco (ELAN) CEO Jeffrey N. Simmons hold after this grant?

After this award, Jeffrey N. Simmons directly holds 24,770.9021 deferred stock units . Each unit is linked on a 1:1 basis to Elanco common stock or its cash equivalent, providing a deferred, equity-linked component within his overall compensation package.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

Simmons Jeffrey N reported acquisition or exercise transactions in this Form 4 filing.

Elanco Animal Health Inc’s president, CEO and director Jeffrey N. Simmons received a grant of 113.8973 deferred stock units on July 10, 2026, referenced at $24.8200 per unit. Following this award, he holds 24,770.9021 deferred stock units directly.

Each deferred stock unit represents the right to receive one share of common stock or the cash equivalent and will settle in cash or shares after termination of employment, or in a specified future year, under the Executive Deferral and Stock Match Plan.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Simmons Jeffrey N

Role PRESIDENT, CEO AND DIRECTOR

Type	Security	Shares	Price	Value
Grant/Award	Deferred Stock Units ^{F1, F2}	113.8973	$24.82	$3K

Holdings After Transaction: Deferred Stock Units — 24,770.9021 shares (Direct)

Footnotes (2)

F1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.
F2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

Key Figures

Deferred stock units granted: 113.8973 units Reference price per deferred stock unit: $24.8200 Deferred stock units held after grant: 24,770.9021 units +1 more

4 metrics

Deferred stock units granted 113.8973 units Grant to Jeffrey N. Simmons on July 10, 2026

Reference price per deferred stock unit $24.8200 Value associated with the July 10, 2026 grant

Deferred stock units held after grant 24,770.9021 units Total direct deferred stock unit holdings following the transaction

Conversion ratio 1 unit = 1 share of common stock Each deferred stock unit represents one share or the cash equivalent

Key Terms

Deferred Stock Units, cash equivalent, Executive Deferral and Stock Match Plan

3 terms

Deferred Stock Units financial

"Each deferred stock unit represents the right to receive one share"

Deferred stock units are promises from a company to give an employee shares of stock at a future date, often after certain conditions are met or after leaving the company. They function like a form of delayed compensation, allowing employees to earn shares over time. For investors, they represent potential future ownership in the company, but do not provide immediate voting rights or dividends until the shares are actually received.

cash equivalent financial

"one share of Company common stock or the cash equivalent"

Executive Deferral and Stock Match Plan financial

"in accordance with Executive Deferral and Stock Match Plan"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/14/2026 - 04:16 PM Accepted by SEC EDGAR 07/14/2026 - 04:15 PM

FAQ

What insider transaction did Elanco (ELAN) CEO Jeffrey N. Simmons report?

Jeffrey N. Simmons reported an acquisition of deferred stock units as part of his compensation. He received 113.8973 deferred stock units, each tied to Elanco common stock or its cash equivalent, under the company’s Executive Deferral and Stock Match Plan.

How many deferred stock units did Elanco (ELAN) grant to its CEO in this report?

Elanco granted its CEO 113.8973 deferred stock units. These units are referenced at $24.8200 per unit and each represents the right to receive one share of Elanco common stock or the cash equivalent in the future, subject to the plan’s terms.

What are deferred stock units in Elanco (ELAN)’s Executive Deferral and Stock Match Plan?

Elanco’s deferred stock units each represent the right to receive one share of company common stock or the cash equivalent. They are part of the Executive Deferral and Stock Match Plan and function as deferred compensation that settles in the future rather than immediately.

When will the Elanco (ELAN) deferred stock units reported by the CEO settle?

The reported deferred stock units will settle in cash or shares after the executive’s termination of employment or during a specified future year. Settlement timing follows the rules of Elanco’s Executive Deferral and Stock Match Plan, rather than occurring at grant date.

How many deferred stock units does Elanco (ELAN) CEO Jeffrey N. Simmons hold after this grant?

After this award, Jeffrey N. Simmons directly holds 24,770.9021 deferred stock units. Each unit is linked on a 1:1 basis to Elanco common stock or its cash equivalent, providing a deferred, equity-linked component within his overall compensation package.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Simmons Jeffrey N

(Last)

(First)

(Middle)

C/O ELANCO ANIMAL HEALTH INCORPORATED

450 ELANCO CIRCLE

(Street)

INDIANAPOLIS

INDIANA

46221

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Elanco Animal Health Inc [ ELAN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	PRESIDENT, CEO AND DIRECTOR

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/10/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Deferred Stock Units	⁽¹⁾	07/10/2026		A		113.8973		⁽²⁾	⁽²⁾	Common Stock	113.8973	$24.82	24,770.9021	D

Explanation of Responses:

1. Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent.

2. Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.

	/s/ Amy C. Seidel, as Attorney-in-Fact for Jeffrey N. Simmons	07/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR